VRDN icon

Viridian Therapeutics

59 hedge funds and large institutions have $72.5M invested in Viridian Therapeutics in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$659K
2 -$646K
3 -$215K
4
Morgan Stanley
Morgan Stanley
New York
-$184K
5
Goldman Sachs
Goldman Sachs
New York
-$132K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$27.8M
2
$8.93M
3
$7.69M
4
$5.59M
5
$3.21M
6
$3.21M
7
$2.28M
8
$1.96M
9
$1.76M
10
$1.38M
11
$1.34M
12
$1.11M
13
$758K
14
$590K
15
$426K
16
$384K
17
$355K
18
$315K
19
$308K
20
$295K
21
$252K
22
$215K
23
$182K
24
$153K
25
$146K